BENZODIAZEPINE RECEPTOR QUANTIFICATION IN-VIVO IN HUMANS USING [C-11] FLUMAZENIL AND PET - APPLICATION OF THE STEADY-STATE PRINCIPLE

被引:173
作者
LASSEN, NA
BARTENSTEIN, PA
LAMMERTSMA, AA
PREVETT, MC
TURTON, DR
LUTHRA, SK
OSMAN, S
BLOOMFIELD, PM
JONES, T
PATSALOS, PN
OCONNELL, MT
DUNCAN, JS
ANDERSEN, JV
机构
[1] NOVO NORDISK AS, DEPT DRUG METAB, DIV CNS, MALOV, DENMARK
[2] HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND
[3] NATL HOSP, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND
关键词
BENZODIAZEPINE RECEPTORS (IN VIVO; FLUMAZENIL; POSITRON EMISSION TOMOGRAPHY; RO; 15-1788;
D O I
10.1038/jcbfm.1995.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carbon-11-labeled flumazenil combined with positron emission tomography (PET) was used to measure the concentration (B-max) of the benzodiazepine (Bz) receptor in the brain and its equilibrium dissociation constant (K-D) for flumazenil in five normal subjects. The steady-state approach was used injecting the tracer as a bolus of high specific activity. In each subject two studies were carried out. The first study was performed at essentially zero receptor occupancy, the tracer alone study. The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged constant infusion of nonlabeled (''cold'') flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period. In this second study the free concentration of unmetabolized flumazenil in plasma water was measured in multiple blood samples. The observed tissue and plasma tracer curves, calibrated in the same units of radioactivity per millimeter, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding number of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments. The noncompartmental and the compartmental analyses gave essentially the same values for the distribution volume of the tracer, the parameter used for quantitation of the Bz receptor. As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred. The five subjects had a mean K-D value of 12 nM/L of water and B-max values of the grey matter ranging from 39 +/- 11 in thalamus to 120 +/- 14 nM/L of brain in occipital cortex. Most previous studies have been based on the pseudoequilibrium approach using the brain stem as a receptor-free reference region. This yields practically the same K-D but lower B-max values than the steady-state approach presented here.
引用
收藏
页码:152 / 165
页数:14
相关论文
共 39 条
  • [1] QUANTIFICATION OF BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN USING PET, [C-11] FLUMAZENIL, AND A SINGLE-EXPERIMENT PROTOCOL
    DELFORGE, J
    PAPPATA, S
    MILLET, P
    SAMSON, Y
    BENDRIEM, B
    JOBERT, A
    CROUZEL, C
    SYROTA, A
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (02) : 284 - 300
  • [2] MEASUREMENT OF BENZODIAZEPINE RECEPTOR NUMBER AND AFFINITY IN HUMANS USING TRACER KINETIC MODELING, POSITRON EMISSION TOMOGRAPHY, AND [C-11] FLUMAZENIL
    PRICE, JC
    MAYBERG, HS
    DANNALS, RF
    WILSON, AA
    RAVERT, HT
    SADZOT, B
    RATTNER, Z
    KIMBALL, A
    FELDMAN, MA
    FROST, JJ
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (04) : 656 - 667
  • [3] NEURORECEPTOR QUANTIFICATION IN-VIVO BY THE STEADY-STATE PRINCIPLE AND [I-123] IOMAZENIL IN RATS
    VIDEBAEK, C
    ANDERSEN, JV
    DALGAARD, L
    FOGED, C
    PAULSON, OB
    LASSEN, AN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (02) : 117 - 122
  • [4] PET ANALYSIS OF [C-11] FLUMAZENIL BINDING TO BENZODIAZEPINE RECEPTORS IN CHRONIC ALCOHOL-DEPENDENT MEN AND HEALTHY CONTROLS
    LITTON, JE
    NEIMAN, J
    PAULI, S
    FARDE, L
    HINDMARSH, T
    HALLDIN, C
    SEDVALL, G
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1993, 50 (01) : 1 - 13
  • [5] [18F]Flumazenil binding to central benzodiazepine receptor studies by PET - Quantitative analysis and comparisons with [11C]flumazenil
    Odano, Ikuo
    Halldin, Christer
    Karlsson, Per
    Varrone, Andrea
    Airaksinen, Anu J.
    Krasikova, Raisa N.
    Farde, Lars
    NEUROIMAGE, 2009, 45 (03) : 891 - 902
  • [6] PET STUDIES OF THE UPTAKE OF (S)-[C-11]NICOTINE AND (R)-[C-11]NICOTINE IN THE HUMAN BRAIN - DIFFICULTIES IN VISUALIZING SPECIFIC RECEPTOR-BINDING IN-VIVO
    NYBACK, H
    HALLDIN, C
    AHLIN, A
    CURVALL, M
    ERIKSSON, L
    PSYCHOPHARMACOLOGY, 1994, 115 (1-2) : 31 - 36
  • [7] MODELING ANALYSIS OF [C-11] FLUMAZENIL KINETICS STUDIED BY PET - APPLICATION TO A CRITICAL-STUDY OF THE EQUILIBRIUM APPROACHES
    DELFORGE, J
    SYROTA, A
    BOTTLAENDER, M
    VARASTET, M
    LOCH, C
    BENDRIEM, B
    CROUZEL, C
    BROUILLET, E
    MAZIERE, M
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (03) : 454 - 468
  • [8] GABA-benzodiazepine receptor function in alcohol dependence:: a combined 11C-flumazenil PET and pharmacodynamic study
    Lingford-Hughes, AR
    Wilson, SJ
    Cunningham, VJ
    Feeney, A
    Stevenson, B
    Brooks, DJ
    Nutt, DJ
    PSYCHOPHARMACOLOGY, 2005, 180 (04) : 595 - 606
  • [9] GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study
    A. R. Lingford-Hughes
    S. J. Wilson
    V. J. Cunningham
    A. Feeney
    B. Stevenson
    D. J. Brooks
    D. J. Nutt
    Psychopharmacology, 2005, 180 : 595 - 606
  • [10] Simultaneous in vivo measurements of receptor density and affinity using [11C] flumazenil and positron emission tomography: Comparison of full saturation and steady state methods
    Syvanen, Stina
    de Lange, Elizabeth C.
    Tagawa, Yoshihiko
    Schenke, Maarten
    Molthoff, Carla F. M.
    Windhorst, Albert D.
    Lammertsma, Adriaan A.
    Voskuyl, Rob A.
    NEUROIMAGE, 2011, 57 (03) : 928 - 937